New Age Alpha Advisors LLC Takes $6.92 Million Position in Encompass Health Co. (NYSE:EHC)

New Age Alpha Advisors LLC purchased a new stake in shares of Encompass Health Co. (NYSE:EHC) in the 4th quarter, HoldingsChannel.com reports. The firm purchased 74,978 shares of the company’s stock, valued at approximately $6,924,000.

Other hedge funds have also bought and sold shares of the company. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares in the last quarter. CBIZ Investment Advisory Services LLC increased its holdings in Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after buying an additional 127 shares in the last quarter. Tompkins Financial Corp acquired a new position in shares of Encompass Health in the fourth quarter worth about $46,000. V Square Quantitative Management LLC grew its position in shares of Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after acquiring an additional 177 shares during the period. Finally, Signaturefd LLC increased its stake in shares of Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company’s stock valued at $65,000 after purchasing an additional 125 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Up 0.8 %

Shares of NYSE:EHC opened at $101.19 on Friday. The business has a 50-day moving average price of $98.55 and a 200 day moving average price of $97.31. The company has a market capitalization of $10.19 billion, a price-to-earnings ratio of 22.69, a PEG ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 12-month low of $78.53 and a 12-month high of $104.55. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Sell-side analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.67%. The ex-dividend date is Tuesday, April 1st. Encompass Health’s payout ratio is presently 15.25%.

Wall Street Analysts Forecast Growth

EHC has been the topic of several recent analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. KeyCorp boosted their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. William Blair restated an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. Finally, Barclays lifted their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, February 7th. Ten research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $107.67.

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.